Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ

NCT06414499 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1386

Enrollment

OTHER

Sponsor class

Conditions

Minor Ischemic Stroke

Interventions

DRUG: rhTNK-tPA
DRUG: Control group (Aspirin combined with clopidogrel)

Sponsor

Beijing Tiantan Hospital